Baxter Actifuse Shape Bone Graft Substitute, Large Cylinder 15mm x 45mm
In Stock: 1 Each
Express: Need it tomorrow? Order in next 2 hours 8 minutes and choose overnight shipping at checkout.
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in-date item only.
Description
Actifuse Shape Bone Graft Substitute
506005078066
- Silicate Substituted Calcium Phosphate
- 8ml Large Cylinder
- Granule Size: 1-2mm
- 15mm x 45mm
Additional information
| Size | 1 |
|---|---|
| Arms | N/A |
| Manufacturer | |
| Type | Biosurgery |
| Unit | box of 1 |
- FDA Product Code: LYC
- FDA Product Code Name: Bone grafting material, synthetic
- GMDN Term Code: 17751
- GMDN Term Name: Bone matrix implant, synthetic, non-antimicrobial
- GMDN Term Description: A bioabsorbable device made of synthetic material intended to be implanted into the body to provide osteoconductive bone-tissue scaffolds, and sometimes osteovascularization, to replace bone lost through trauma, surgery, or pathological conditions (e.g., osteoporosis); it does not include an antimicrobial agent(s). It may be made of ceramics (e.g., tricalcium phosphate or hydroxyapatite), bioactive glasses/minerals/metals (e.g., strontium), or bioabsorbable polymers. It is used to fill cystic defects, repair fractures, and/or extend autogenous bone grafts and is typically provided as cancellous blocks, chips, or granules of varying sizes, or mouldable/fluid materials.
Baxter
Baxter provides a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
